Developing new methods for creating drugs using light and special materials
Bioinspired selective heterogeneous organic photoredox catalysis
This study is exploring a new way to make medicines using special light-driven reactions, which could lead to better and safer drugs for patients who need them.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Southern Illinois University Carbondale NIH-funded |
| Lab location | 1 site (Carbondale, United States) |
| Project ID | NIH-10580485 on NIH RePORTER |
What this research studies
This research focuses on using innovative light-driven chemical reactions to create new drugs that are difficult to synthesize with traditional methods. By employing unique materials known as porous crystalline molecular frameworks, the project aims to enhance the efficiency and selectivity of these reactions. The approach addresses challenges related to how quickly and effectively the necessary components can interact, which is crucial for producing effective medications. Patients may benefit from the development of new drugs that are more effective and have fewer side effects.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from new drug therapies, particularly those with conditions that current medications do not adequately address.
Not a fit: Patients who are not seeking new drug therapies or those with conditions that are already well-managed by existing medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new, more effective drugs for various medical conditions.
How similar studies have performed: While the approach of using light-driven reactions in drug synthesis is gaining interest, this specific methodology involving porous crystalline frameworks is relatively novel and has not been extensively tested.
Where this research is happening
Carbondale, United States
- Southern Illinois University Carbondale — Carbondale, United States (Active)
Researchers
- Principal investigator: Deria, Pravas — Southern Illinois University Carbondale
- Study coordinator: Deria, Pravas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.